Astrana Health Named Profitable Stock to Watch, AT&T and Payoneer Flagged as Sells

StockStory··Read original
2▲1 ▼2Impact / 5
Summary · why it matters

StockStory identifies Astrana Health as a profitable stock to target this week, while questioning AT&T and Payoneer. Astrana Health, formerly Apollo Medical Holdings, reported a 55.7% annual revenue growth over the last two years and a 13.2% annual increase in earnings per share over five years, with a forward P/E of 15.3. AT&T faces annual revenue declines of 1.3% over five years and a 7.5% annual drop in earnings per share, trading at 9 times forward P/E. Payoneer's earnings per share growth of 4.8% underperformed its revenue, and its return on equity stands at 7.3%, with shares at 25 times forward P/E.

Impact on assets 3

Aging Population▲ · 1 stocks
Astrana Health Inc
ASTH
▲ PositiveCapitalrelevance

StockStory highlights Astrana Health's strong revenue and earnings growth and low forward P/E as a profitable stock to watch.

Digital Finance & Tokenization▼ · 1 stocks
Payoneer Global Inc
PAYO
▼ NegativeCapitalrelevance

StockStory flags Payoneer as a sell due to weak earnings growth relative to revenue and low return on equity.

Cloud & Digital Infrastructure▼ · 1 stocks
AT&T Inc.
T
▼ NegativeCapitalrelevance

StockStory flags AT&T as a sell due to declining revenue and earnings per share over five years.

© 2026 MarketIVNews